日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Feasibility of Intratumoral Administration With EPHB4-CAR-T Cells for the Treatment of Oral Squamous Cell Carcinoma

EPHB4-CAR-T细胞瘤内注射治疗口腔鳞状细胞癌的可行性研究

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70023
Ito, Yusuke; Suzuki, Toshihiro; Shimomura, Manami; Takenouchi, Kazumasa; Ohnuki, Kazunobu; Shoda, Kayoko; Kenmochi, Yuka; Yagyu, Shigeki; Matsuura, Kazuto; Hayashi, Ryuichi; Nakatsura, Tetsuya
EPHB4
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer

循环肿瘤相关细胞外囊泡作为胰腺癌早期检测和复发生物标志物

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15500
Yoshioka, Yusuke; Shimomura, Manami; Saito, Keigo; Ishii, Hideshi; Doki, Yuichiro; Eguchi, Hidetoshi; Nakatsura, Tetsuya; Itoi, Takao; Kuroda, Masahiko; Mori, Masaki; Ochiya, Takahiro
肿瘤
肿瘤免疫
细胞生物学
囊泡
胰腺癌
发表日期：2022
文献求助 收藏

Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances

肽类疫苗在肝细胞癌治疗中的应用：近期进展综述

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S291558
Charneau, Jimmy; Suzuki, Toshihiro; Shimomura, Manami; Fujinami, Norihiro; Nakatsura, Tetsuya
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer

新辅助治疗后Ki67表达和T细胞定位作为直肠癌可靠的预测标志物

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.14223
Imaizumi, Ken; Suzuki, Toshihiro; Kojima, Motohiro; Shimomura, Manami; Sakuyama, Naoki; Tsukada, Yuichiro; Sasaki, Takeshi; Nishizawa, Yuji; Taketomi, Akinobu; Ito, Masaaki; Nakatsura, Tetsuya
T细胞
T细胞
免疫/内分泌
肿瘤
肠癌
细胞生物学
肿瘤免疫
发表日期：2020
文献求助 收藏

First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors

IT1208（一种去岩藻糖基化人源化抗CD4耗竭抗体）在晚期实体瘤患者中的首次人体I期研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0677-y
Shitara, Kohei; Ueha, Satoshi; Shichino, Shigeyuki; Aoki, Hiroyasu; Ogiwara, Haru; Nakatsura, Tetsuya; Suzuki, Toshihiro; Shimomura, Manami; Yoshikawa, Toshiaki; Shoda, Kayoko; Kitano, Shigehisa; Yamashita, Makiko; Nakayama, Takayuki; Sato, Akihiro; Kuroda, Sakiko; Wakabayashi, Masashi; Nomura, Shogo; Yokochi, Shoji; Ito, Satoru; Matsushima, Kouji; Doi, Toshihiko
T细胞
CD4
发表日期：2019
文献求助 收藏

Higher human lymphocyte antigen class I expression in early-stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes

早期癌细胞中人类淋巴细胞抗原I类分子的高表达导致其对细胞毒性T淋巴细胞的高度敏感性。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.14022
Akazawa, Yu; Nobuoka, Daisuke; Takahashi, Mari; Yoshikawa, Toshiaki; Shimomura, Manami; Mizuno, Shoichi; Fujiwara, Toshiyoshi; Nakamoto, Yasunari; Nakatsura, Tetsuya
细胞生物学
肿瘤
毒理研究
肿瘤免疫
发表日期：2019
文献求助 收藏

Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial

NCCV Cocktail-1疫苗治疗难治性儿童实体瘤的疗效：一项I期临床试验

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.14206
Akazawa, Yu; Hosono, Ako; Yoshikawa, Toshiaki; Kaneda, Hide; Nitani, Chika; Hara, Junichi; Kinoshita, Yoshiaki; Kohashi, Kenichi; Manabe, Atsushi; Fukutani, Miki; Wakabayashi, Masashi; Sato, Akihiro; Shoda, Kayoko; Shimomura, Manami; Mizuno, Shoichi; Nakamoto, Yasunari; Nakatsura, Tetsuya
发表日期：2019
文献求助 收藏

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors

针对难治性儿童实体瘤患者的糖蛋白聚糖-3衍生肽疫苗疗法的I期研究

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2017.1377872
Tsuchiya, Nobuhiro; Hosono, Ako; Yoshikawa, Toshiaki; Shoda, Kayoko; Nosaka, Kazuto; Shimomura, Manami; Hara, Junichi; Nitani, Chika; Manabe, Atsushi; Yoshihara, Hiroki; Hosoya, Yosuke; Kaneda, Hide; Kinoshita, Yoshiaki; Kohashi, Kenichi; Yoshimura, Kenichi; Fujinami, Norihiro; Saito, Keigo; Mizuno, Shoichi; Nakatsura, Tetsuya
发表日期：2017
文献求助 收藏

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.

围手术期血浆糖蛋白聚糖-3 水平可能有助于预测 I 期肝细胞癌患者术后复发的风险

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.14271
Ofuji Kazuya, Saito Keigo, Suzuki Shiro, Shimomura Manami, Shirakawa Hirofumi, Nobuoka Daisuke, Sawada Yu, Yoshimura Mayuko, Tsuchiya Nobuhiro, Takahashi Mari, Yoshikawa Toshiaki, Tada Yoshitaka, Konishi Masaru, Takahashi Shinichiro, Gotohda Naoto, Nakamoto Yasunari, Nakatsura Tetsuya
细胞生物学
肿瘤免疫
发表日期：2017
文献求助 收藏

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model

肽疫苗联合抗CD4抗体增强抗肿瘤作用：小鼠模型研究

期刊:Biochemistry and Biophysics Reports
影响因子:2.2
doi:10.1016/j.bbrep.2016.02.010
Fujinami, Norihiro; Yoshikawa, Toshiaki; Sawada, Yu; Shimomura, Manami; Iwama, Tatsuaki; Sugai, Shiori; Kitano, Shigehisa; Uemura, Yasushi; Nakatsura, Tetsuya
肿瘤
T细胞
CD4
肿瘤免疫
发表日期：2016
文献求助 收藏